How magnesium therapy may influence clinical outcome in acute myocardial infarction: Review of potential mechanisms

Coronary Artery Disease

Volumn 7, Issue 5, 1996, Pages 364-371

  Herzog, William R ^a   Serebruany, Victor L ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

acute myocardial infarction; humans; magnesium; mechanisms

Indexed keywords

MAGNESIUM;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL TISSUE; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SWINE; TREATMENT OUTCOME;

EID: 0029788111     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199605000-00006     Document Type: Review

References (50)

1. Wacker WEC, Parisi AF: Magnesium metabolism. N Engl J Med 1968, 278:658-663.
2. White RE, Hartzell HC: Magnesium ions in cardiac function: regulator of ion channels and second messengers. Biochem Pharmacol 1989, 38:859-867.
3. Woods KL: Possible pharmacologic actions of magnesium in acute myocardial infarction. Br J Clin Pharmacol 1991, 32:3-10.
4. Reinhart RA: Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system. Am Heart J 1991, 121:1513-1521.
5. Iseri LT, French JH: Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984, 108:188-193.
6. Watanabe Y, Dreifus LS: Electrophysiologic effects of magnesium and its interaction with potassium. Cardiovasc Res 1972, 6:79-88.
7. Di Carlo LAJ, Morady F, de Buitler M, Krol RB, Schurig L, Annesley TM: Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 1986, 7:1356-1362.
8. Rasmussen HS, Thomsen PEB: The electrophysiologic effects of intravenous magnesium on human sinus node, atrioventricular node, atrium and ventricle. Clin Cardiol 1989, 12:85-90.
9. Stanbury JB, Fara A: Effects of the magnesium ion on heart and on its response to digoxin. J Pharmacol Exp Ther 1950, 100:445-453.
10. Tzivoni D, Banai S, Schuger C, Benhorin J, Keren A, Gottlieb S, et al.: Treatment of torsade de pointes with magnesium sulfate. Circulation 1988, 77:392-397.
11. Horner SM: Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Circulation 1992, 86:774-779.
12. Woods KL, Fletcher S, Roffe C, Haider Y: Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet 1992, 339:1553-1558. This well-conducted and well-designed trial is the most convincing clinical evidence to date that magnesium therapy is useful.
13. ISIS collaborative group: ISIS-4: randomized study of intravenous magnesium in over 50,000 patients with suspected acute myocardial infarction. Lancet 1995, 345:669-685. This is the most recent and the largest clinical trial of magnesium in AMI.
14. Mergner G, Weglicki W, Kramer J: Postischemic free radical production in the venous blood of the regionally ischemic swine heart. Circulation 1991, 84:2079-2090.
15. Dickens BF, Weglicki WB, Li Y-S, Mak IT: Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992, 311:187-191.
16. Herzog WR, Atar D, Mak IT, Alyono D, MacCord C, Weglicki WB: Magnesium deficiency prolongs myocardial stunning in an open-chest swine model. Int J Cardiol 1994, 47:105-115.
17. Bolli R: Myocardial stunning in man. Circulation 1992, 86:1671-1691.
18. Bolli R: Mechanism of myocardial stunning. Circulation 1990, 82: 723-738.
19. 2+ transients underlie 'stunning'? Circ Res 1990, 66:1268-1276.
20. Steenbergen C, Murphy E, Levy L, London RE: Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987, 60:700-707.
21. Dunnen J, Nayler WG: Calcium efflux from cardiac sarcoplasmic reticulum: effects of calcium and magnesium. J Mol Cell Cardiol 1978, 10:487-498.
22. Krause SM, Jacobus WE, Becker LC: Alterations in cardiac sarcoplasmic reticulum transport in the post ischemic 'stunned' myocardium. Circ Res 1989, 65:526-530.
23. Lamers JMJ, Duncker DJ, Bezstarosti K, McFalls EO, Sassen LMA, Verdouw PD: Increased activity of the sarcoplasmic reticular calcium pump in porcine stunned myocardium. Cardiovasc Res 1993, 27:520-524.
24. Paulus WJ, Vantrimpont PJ, Shah AM: Paracrine coronary endothetial control of left ventricular function in humans. Circulation 1995, 92:2119-2126.
25. Nadler JL, Goodson S, Rude RK: Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987, 9:379-383.
26. du Toit EF, Opie LH: Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res 1992, 70:960-967. This research strongly supports the calcium-related hypothesis of reperfusion injury and its relationship to the phenomonon of stunning.
27. Atar D, Serebruany V, Poulton J, Godard J, Schneider A, Herzog WR: Effects of magnesium supplementation in a porcine model of myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1994, 24:603-611.
28. Herzog WR, Atar D: Magnesium and myocardial infarction [letter]. Lancet 1994, 343:1225.
29. Woods KL, Fletcher S: Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994, 343:816-819.
30. Barros LFM, Chagas ACP, da Luz PI, Pileggi F: Magnesium treatment of acute myocardial infarction: effects on necrosis in an occlusion/ reperfusion dog model. Int J Cardiol 1995, 48:3-9.
31. Christensen CW, Rieder MA, Silverstein EL, Genchoff NE: Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation 1995, 92:2617-2621. This article demonstrates the potentially critical importance of the timing of magnesium therapy.
32. Herzog WR, Schlossberg ML, MacMurdy KS, Edenbum LR, Gerber MJ, Vogel RA, et al.: Timing of magnesium therapy affects experimental infarct size. Circulation 1995, 92:2622-2626. This article demonstrates two important concepts: the effects of timing of administration and the fact that benefit can be achieved by treatment limited to the reperfusion phase.
33. Leor J, Kloner RA: An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995, 75:1292-1293.
34. +2 overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 1989, 65:1045-1056.
35. Shen AC, Jennings RB: Myocardial calcium and magnesium in acute ischemic injury. Am J Pathol 1972, 67:417-440.
36. Hearse DJ, Stewart DA, Braimbridge MV: Myocardial protection during ischemic cardiac arrest. J Thorac Cardiovasc Surg 1978, 75:877-885.
37. Bersohn MM, Shine KI, Sterman WD: Effect of increased magnesium on recovery from ischemia in rat and rabbit hearts. Am J Physiol 1982, 242:H89-H93.
38. Mroczek WJ, Lee WR, Davidov ME: Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 1977, 28:720-724.
39. Watson KV, Moldow CF, Ogburn PL, Jacob HS: Magnesium sulfate: rationale for its use in pre-eclampsia. Proc Natl Acad Sci U S A 1986, 83:1075-1078.
40. Oliva PG, Breckenridge JC: Arteriographic evidence of coronary artery spasm in acute myocardial infarction. Circulation 1977, 56:366-374.
41. Altura BT, Altura BM: Endothelium dependent relaxation in coronary arteries requires magnesium ions. Br J Pharmacol 1987, 91:449-451.
42. Kimura T, Yasue H, Sakaino N, Rokutanda M, Jougasaki M, Araki H: Effects of magnesium on the tone of isolated human coronary arteries. Circulation 1989, 79:1118-1124.
43. G-nitro-L-arginine methyl ester, in conscious rats. Clin Sci 1993, 85:175-181.
44. Petersen OB, Skajaa K, Svane D, Gregersen H, Forman A: The effects of dihydralazine, labetalol and magnesium sulfate on the isolated, perfused human placental cotyledon. Br J Obst Gynaecol 1994, 101:871-878.
45. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991, 69:370-377.
46. Velasco CE, Jackson EK, Morrow JA, Vitola JV, Inagmi T, Forman MB: Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischemia and reperfusion. Cardiovasc Res. 1993, 27:121-128.
47. Rishi M, Ahmad A, Makheja A, Karcher D, Bloom S: Effects of reduced dietary magnesium on platelet production and function in hamsters. Lab Invest 1990, 63:717-721.
48. Gawaz M, Ott I, Reininger AJ, Neumann F-J: Effects of magnesium on platelet aggregation and adhesion. Thromb Haemost 1994, 72:912-918.
49. Adams JH, Mitchell JRA: The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo. Thromb Haemost 1979, 42:603-610.
50. Hwang D, Yen C, Nadler J: Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens 1992, 5:700-706.